Rising incidences of cancer and cardiovascular diseases are the key factor driving market revenue growth

VANCOUVER, BRITISH COLUMBIA, CANADA, June 12, 2023/EINPresswire.com/ -- The global nuclear medicine market size reached USD 9.15 Billion in 2022 and is expected to register a revenue CAGR of 12.90% during the forecast period, according to latest analysis by Emergen Research. Nuclear medicine market revenue growth is driven by factors such as increasing prevalence of cancer and cardiovascular diseases, development of alpha-radioimmunotherapy-based targeted cancer treatments, using of radiopharmaceuticals in neurological applications, and rising demand for accurate diagnostic methods.

Millions of patients across the globe benefit from the daily use of radiation medicine. Certain methods permit medical practitioners to create digital images of internal organs by utilizing short-lived radioisotopes, which are subsequently detected and translated into images, forming the basis of nuclear medicine techniques. A variety of chemicals have been identified by scientists that are absorbed by particular organs, and as a result, various radiopharmaceuticals have been developed.

Revenue growth of the market is being driven by rising prevalence of cancer and Cardiovascular Disease (CVD). The American Cancer Society projects that approximately 268,490 individuals will be diagnosed with prostate cancer in the United States in 2022, with around 34,500 expected deaths. The majority of diagnoses are in men aged 65 years and above, with very few cases occurring in men under 40 years of age.

Get a Sample PDF:

https://www.emergenresearch.com/request-sample/1865

Scope of the Report

The research study on the global Nuclear Medicine market is split into three parts: product type, application, and area. Each section is divided into chapters that cover different themes. In each chapter, there are graphs that show growth from one year to the next, as well as what causes growth and what stops it. Also, the study shows what the government thinks will happen in regional markets that have an effect on the world business of drugs to treat brain metastases.

Ask for Customization:

https://www.emergenresearch.com/request-for-customization/1865

Key Companies Profiled in the Report are:

GE Healthcare, Lantheus, Nordion (Canada) Inc, Novartis AG, EczacıbaÅı-Monrol, Bayer AG, Cardinal Health., Siemens Healthcare GmbH, Bracco, Isotope JSC

Outlook for the Region:

This Research Consider the following Regions:

North America (U.S., Canada, Mexico)

Europe (U.K., Italy, Germany, France, Rest of the EU)

Asia-Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Research Methodology

Our team of analysts has performed an accurate analysis of significant market elements leveraging advanced primary and secondary research tools. They have deployed well-known analytical tools like SWOT Analysis and Porter’s Five Forces Analysis for the comprehensive market study. A great deal of vital data & information related to the Nuclear Medicine market has been gathered in the report from various reliable sources. Under the primary research study, detailed supply chain analysis, value chain analysis, several industry experts’ interviews, and a brief analysis of the Nuclear Medicine market’s vendor landscape have been covered. Therefore, as part of secondary research, the report offers vital information pertaining to the company profiles of the key market contenders. Hence, the report’s market segmentation section looks at the global sector to scrutinize key trends, regional markets, and recent industry developments.

Global Nuclear Medicine Market Segmentation by Regions:

The countries covered in the regional analysis of the Global Nuclear Medicine Market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.

Product Outlook (Revenue, USD Billion; 2019-2032)
Diagnostic Products

SPECT

Tc-99m

TI-201

Ga-67

I-123

Other Spect Products

PET

F-18

Sr-82/Rb-82

Other Pet products

Therapeutic Products

Alpha Emitters

Ra-223

Beta Emitters

I- 131

Y-90

Sm-153

Re-186

Lu-177

Other Beta Emitters

Brachytherapy

Cesium-131

Iodine-125

Palladium-103

Iridium-192

Other Brachytherapy Products

Application Outlook (Revenue, USD Billion; 2019-2032)
Cardiology

Neurology

Oncology

Thyroid

Lymphoma

Bone Metastasis

Endocrine Tumor

Other Applications

End-Use Outlook (Revenue, USD Billion; 2019-2032)
Diagnostic Centers

Hospitals & Clinics

Others

To get a discount on the latest report, visit:

https://www.emergenresearch.com/request-discount/1865

Table of Content

Chapter 1. Methodology & Sources

1.1. Market Definition

1.2. Research Scope

1.3. Methodology

1.4. Research Sources

1.4.1. Primary

1.4.2. Secondary

1.4.3. Paid Sources

1.5. Market Estimation Technique

Chapter 2. Executive Summary

2.1. Summary Snapshot, 2023–2032

Chapter 3. Key Insights

Chapter 4. Nuclear Medicine Market Segmentation & Impact Analysis

4.1. Nuclear Medicine Market Segmentation Analysis

4.2. Industrial Outlook

4.2.1. Market indicators analysis

Competitive Outlook:

The global Nuclear Medicine market is highly consolidated due to the presence of a large number of companies across this industry. These companies are known to make hefty investments in research and development projects. Moreover, they control a considerable portion of the overall market share, thus limiting the entry of new players into the sector.

The global Nuclear Medicine market report studies the prudent tactics undertaken by the leading market players, such as partnerships and collaborations, mergers & acquisitions, new product launches, and joint ventures.

For complete Report visit us @ https://www.emergenresearch.com/industry-report/nuclear-medicine-market

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.